Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 19033714)

Published in Oncology on November 26, 2008

Authors

Aristides Polyzos1, Nikolas Tsavaris, Hellen Gogas, John Souglakos, Lambros Vambakas, Nikolaos Vardakas, Kostas Polyzos, Christos Tsigris, Demetrios Mantas, Antonios Papachristodoulou, Nikolas Nikiteas, John G Karavokyros, Evangelos Felekouras, John Griniatsos, Athanasios Giannopoulos, Gregory Kouraklis

Author Affiliations

1: Medical Oncology Unit, Laiko General Hospital, Athens University School of Medicine, Athens, Greece. panoraiap@med.uoa.gr

Articles by these authors

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med (2011) 4.51

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer. Hum Mol Genet (2004) 2.05

Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80

Infected femoral artery pseudoaneurysm in drug addicts: the beneficial use of the internal iliac artery for arterial reconstruction. J Vasc Surg (2007) 1.66

Trauma management in ancient Greece: value of surgical principles through the years. World J Surg (2004) 1.64

Ghrelin's role on gastrointestinal tract cancer. Surg Oncol (2009) 1.55

Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52

Percutaneous cholecystostomy without interval cholecystectomy as definitive treatment of acute cholecystitis in elderly and critically ill patients. South Med J (2008) 1.50

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients. PLoS One (2008) 1.43

Liver tissue dissection: ultrasonic or RFA energy? World J Surg (2006) 1.43

A Malignant Gastrointestinal Stromal Tumor of the Gallbladder Immunoreactive for PDGFRA and Negative for CD 117 Antigen (c-KIT). HPB Surg (2011) 1.39

Current treatment for colorectal liver metastases. World J Gastroenterol (2011) 1.38

Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study. Invest New Drugs (2005) 1.34

Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study. Cancer (2013) 1.31

DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer (2009) 1.30

Clinical considerations and therapeutic strategy for sigmoid volvulus in the elderly: a study of 33 cases. World J Gastroenterol (2007) 1.27

Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients. PLoS One (2011) 1.27

Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg (2002) 1.24

The ALPPS procedure for extended indications in liver surgery: an old finding applied in surgical oncology. Ann Surg (2013) 1.19

Bile duct injuries associated with laparoscopic and open cholecystectomy: an 11-year experience in one institute. Surg Today (2005) 1.18

Small intestine diverticula: Is there anything new? World J Gastrointest Surg (2011) 1.15

Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat Rev (2004) 1.15

Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene (2002) 1.15

Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen. Clin Cancer Res (2009) 1.14

ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer. J Thorac Oncol (2012) 1.10

Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis. Anticancer Res (2008) 1.10

Emergency liver resection for combined biliary and vascular injury following laparoscopic cholecystectomy: case report and review of the literature. South Med J (2007) 1.09

Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer. Mod Pathol (2007) 1.09

Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study. BMC Cancer (2007) 1.08

The role of abdominal imaging in cases with a high probability of acute left-sided colonic diverticulitis based on a clinical scoring system. Ann Surg (2013) 1.07

Present treatment and future expectations in advanced pancreatic cancer. Anticancer Res (2008) 1.06

Laparoscopic gastric plication for the treatment of morbid obesity: a review. Minim Invasive Surg (2012) 1.03

Comparison of open and laparoscopic prosthetic repair of large ventral hernias. JSLS (2003) 1.03

Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res (2010) 1.02

Insights on augmenter of liver regeneration cloning and function. World J Gastroenterol (2006) 1.01

CYP2E1 and risk of chemically mediated cancers. Expert Opin Drug Metab Toxicol (2010) 1.01

Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients. Eur J Clin Invest (2011) 1.00

Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma. Am J Surg (2013) 0.99

Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer (2005) 0.97

Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis (2011) 0.96

Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res (2007) 0.96

High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study. Lung Cancer (2004) 0.95

A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer. Anticancer Res (2003) 0.94

Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance. Virchows Arch (2007) 0.93

Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients. Head Neck (2013) 0.92

Coexistence of hepatocellular carcinoma (HCC) and c-Kit negative gastrointestinal stromal tumor (GIST): a case report. South Med J (2008) 0.92

Malignant carcinoid tumor of the cystic duct: a rare cause of bile duct obstruction. Hepatobiliary Pancreat Dis Int (2009) 0.92

Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene (2002) 0.92

Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide. PLoS One (2013) 0.92

Morbid obesity and sleeve gastrectomy: how does it work? Obes Surg (2010) 0.92

Reliability of panoramic radiograph for carotid atheroma detection: a study in patients who fulfill the criteria for carotid endarterectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 0.91

Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer. World J Gastroenterol (2010) 0.91

Management of early and late detected vascular complications following femoral arterial puncture for cardiac catheterization. Hellenic J Cardiol (2007) 0.90

Bacterial translocation, endotoxaemia and apoptosis following Pringle manoeuvre in rats. Injury (2004) 0.90

True giant common hepatic artery aneurysm associated with obstructive jaundice: a case report. Int Surg (2002) 0.90

NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links. Expert Opin Ther Targets (2014) 0.89

Heterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancer. Anticancer Res (2008) 0.89

Ghrelin: a potential therapeutic target for cancer. Regul Pept (2010) 0.89

Autologous transplantation of adipose-derived stem cells enhances skin graft survival and wound healing in diabetic rats. Ann Plast Surg (2013) 0.89

Malondialdehyde as an indicator of oxidative stress during abdominal aortic aneurysm repair. Angiology (2007) 0.89

Giant pedunculated hepatocellular carcinoma with hemangioma mimicking intestinal obstruction. BMC Gastroenterol (2011) 0.88

Emergency stenting of a ruptured infected anastomotic femoral pseudoaneurysm. Cardiovasc Intervent Radiol (2007) 0.87

Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer. J Surg Oncol (2010) 0.87

Apolipoprotein J and leptin levels in patients with coronary heart disease. In Vivo (2008) 0.87

Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study. Anticancer Res (2012) 0.86

Superior mesenteric artery dissection after extracorporeal shockwave lithotripsy. Case Rep Vasc Med (2012) 0.86

ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Cancer Invest (2015) 0.85

Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol (2008) 0.85

Global financial crisis and surgical practice: the Greek paradigm. World J Surg (2011) 0.85

Laparoscopic cholecystectomy in cirrhotic patients with symptomatic gallstone disease. ANZ J Surg (2008) 0.85

Laparoscopic adrenalectomy: where do we stand now? Tohoku J Exp Med (2010) 0.84

FGFR-2 and -3 play an important role in initial stages of oral oncogenesis. Anticancer Res (2007) 0.84

Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution. Gynecol Oncol (2008) 0.84

Survival in patients with stage IV noncardia gastric cancer - the influence of DNA ploidy and Helicobacter pylori infection. BMC Cancer (2012) 0.84

Initial experience with robotic sleeve gastrectomy for morbid obesity. Obes Surg (2011) 0.84

Ghrelin, another factor affecting bone metabolism. Med Sci Monit (2010) 0.84

Robotic versus laparoscopic surgery: perspectives for tailoring an optimal surgical option. Expert Rev Med Devices (2011) 0.84

Preoperative serum lactate dehydrogenase levels in colorectal and gastric cancer: a hospital-based case-control study. Biomark Med (2013) 0.83

Primary stenting for aortic lesions: from single stenoses to total aortoiliac occlusions. J Vasc Surg (2008) 0.83

Outcome analysis of laparoscopic cholecystectomy in patients aged 80 years and older with complicated gallstone disease. J Laparoendosc Adv Surg Tech A (2007) 0.83

Prognostic and predictive value of thymidylate synthase expression in colon cancer. Dig Dis Sci (2007) 0.83

Histone acetylation and cancer. Acta Oncol (2003) 0.83

Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006. Anticancer Res (2009) 0.83

Fibrinolytic and coagulation pathways after laparoscopic and open surgery: a prospective randomized trial. Surg Endosc (2009) 0.83